Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in KRAS-Mutant Lung Adenocarcinoma.

Galan-Cobo A, Sitthideatphaiboon P, Qu X, Poteete A, Pisegna MA, Tong P, Chen PH, Boroughs LK, Rodriguez MLM, Zhang W, Parlati F, Wang J, Gandhi V, Skoulidis F, DeBerardinis RJ, Minna JD, Heymach JV.

Cancer Res. 2019 Jul 1;79(13):3251-3267. doi: 10.1158/0008-5472.CAN-18-3527. Epub 2019 Apr 30.

PMID:
31040157
2.

Combined effects of aquaporin-4 and hypoxia produce age-related hydrocephalus.

Trillo-Contreras JL, Ramírez-Lorca R, Hiraldo-González L, Sánchez-Gomar I, Galán-Cobo A, Suárez-Luna N, Sánchez de Rojas-de Pedro E, Toledo-Aral JJ, Villadiego J, Echevarría M.

Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3515-3526. doi: 10.1016/j.bbadis.2018.08.006. Epub 2018 Aug 8.

3.

The Expression of AQP1 IS Modified in Lung of Patients With Idiopathic Pulmonary Fibrosis: Addressing a Possible New Target.

Galán-Cobo A, Arellano-Orden E, Sánchez Silva R, López-Campos JL, Gutiérrez Rivera C, Gómez Izquierdo L, Suárez-Luna N, Molina-Molina M, Rodríguez Portal JA, Echevarría M.

Front Mol Biosci. 2018 May 3;5:43. doi: 10.3389/fmolb.2018.00043. eCollection 2018.

4.

STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.

Skoulidis F, Goldberg ME, Greenawalt DM, Hellmann MD, Awad MM, Gainor JF, Schrock AB, Hartmaier RJ, Trabucco SE, Gay L, Ali SM, Elvin JA, Singal G, Ross JS, Fabrizio D, Szabo PM, Chang H, Sasson A, Srinivasan S, Kirov S, Szustakowski J, Vitazka P, Edwards R, Bufill JA, Sharma N, Ou SI, Peled N, Spigel DR, Rizvi H, Aguilar EJ, Carter BW, Erasmus J, Halpenny DF, Plodkowski AJ, Long NM, Nishino M, Denning WL, Galan-Cobo A, Hamdi H, Hirz T, Tong P, Wang J, Rodriguez-Canales J, Villalobos PA, Parra ER, Kalhor N, Sholl LM, Sauter JL, Jungbluth AA, Mino-Kenudson M, Azimi R, Elamin YY, Zhang J, Leonardi GC, Jiang F, Wong KK, Lee JJ, Papadimitrakopoulou VA, Wistuba II, Miller VA, Frampton GM, Wolchok JD, Shaw AT, Jänne PA, Stephens PJ, Rudin CM, Geese WJ, Albacker LA, Heymach JV.

Cancer Discov. 2018 Jul;8(7):822-835. doi: 10.1158/2159-8290.CD-18-0099. Epub 2018 May 17.

5.

Role of aquaporins in cell proliferation: What else beyond water permeability?

Galán-Cobo A, Ramírez-Lorca R, Echevarría M.

Channels (Austin). 2016;10(3):185-201. doi: 10.1080/19336950.2016.1139250. Epub 2016 Jan 11. Review.

6.

Overexpression of AQP3 Modifies the Cell Cycle and the Proliferation Rate of Mammalian Cells in Culture.

Galán-Cobo A, Ramírez-Lorca R, Serna A, Echevarría M.

PLoS One. 2015 Sep 14;10(9):e0137692. doi: 10.1371/journal.pone.0137692. eCollection 2015.

7.

Aquaporin-1 plays important role in proliferation by affecting cell cycle progression.

Galán-Cobo A, Ramírez-Lorca R, Toledo-Aral JJ, Echevarría M.

J Cell Physiol. 2016 Jan;231(1):243-56. doi: 10.1002/jcp.25078.

PMID:
26081645
8.

Functional inhibition of aquaporin-3 with a gold-based compound induces blockage of cell proliferation.

Serna A, Galán-Cobo A, Rodrigues C, Sánchez-Gomar I, Toledo-Aral JJ, Moura TF, Casini A, Soveral G, Echevarría M.

J Cell Physiol. 2014 Nov;229(11):1787-801. doi: 10.1002/jcp.24632.

PMID:
24676973
9.

Cellular overexpression of aquaporins slows down the natural HIF-2α degradation during prolonged hypoxia.

Galán-Cobo A, Sánchez-Silva R, Serna A, Abreu-Rodríguez I, Muñoz-Cabello AM, Echevarría M.

Gene. 2013 Jun 10;522(1):18-26. doi: 10.1016/j.gene.2013.03.075. Epub 2013 Mar 29.

PMID:
23545307
10.

Targeting aquaporin function: potent inhibition of aquaglyceroporin-3 by a gold-based compound.

Martins AP, Marrone A, Ciancetta A, Galán Cobo A, Echevarría M, Moura TF, Re N, Casini A, Soveral G.

PLoS One. 2012;7(5):e37435. doi: 10.1371/journal.pone.0037435. Epub 2012 May 18.

Supplemental Content

Loading ...
Support Center